• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of novel therapeutics for the preventions of cervical cancer

Research Project

Project/Area Number 15K12518
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Biomedical engineering/Biomaterial science and engineering
Research InstitutionKyoto Prefectural University

Principal Investigator

Tsukamoto Yasuhiro  京都府立大学, 生命環境科学研究科, 教授 (90305657)

Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords子宮頸がん / 抗体 / HPV / ダチョウ / ダチョウ抗体 / 子宮頸癌 / HPV
Outline of Final Research Achievements

In the present study, we have developed ostrich IgY against HPV proteins. The IgY could bind specifically to HPV proteins and neutralize the viral infections to culture cells even in the lower dosages. These results suggested that IgY against HPV proteins blocked the viral adsorptions onto cell cell surface of culture cells and inhibited the viral infections. The IgY might have a potential to inhibit and prevention of HPV infections in humans by applying in love lotions etc, leading to prevention of cervical cancers. We need further in vivo and clinical studies to clarify this point.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (1 results)

All Other

All Int'l Joint Research (1 results)

  • [Int'l Joint Research] ハーバード大学医学部(米国)

    • Related Report
      2017 Annual Research Report

URL: 

Published: 2015-04-16   Modified: 2022-06-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi